irAE	Immune-related adverse event
ICI	Immune checkpoint inhibitor
irBP	Immune-related bullous pemphigoid
IL-4	Interleukin-4
IL-13	Interleukin-13
BP	Bullous pemphigoid
DEG	Differentially expressed genes
EMA	European Medicines Agency
H&E	Hematoxylin and Eosin
IL-4Rα	Interleukin-4 receptor alpha chain
AJCC	American Joint Committee on Cancer
MHH	Medizinische Hochschule Hannover
NCT	National Center for Tumor Diseases
FFPE	Formalin-fixed and paraffin-embedded
PEA	Pathway enrichment analysis
OS	Overall survival
PFS	Progression-free survival
JAK	Janus kinase
TLR	Toll-like receptor
TNF	Tumor necrosis factor
NCCN	National Cancer Comprehensive Network
NSCLC	Non-small-cell lung cancer
ORR	Overall response rate
Treg	Regulatory T-cells
Th	T-helper cells
TYK2	Tyrosine Kinase 2